Latest Content

Beacon Gene Therapy: 2024 ASGCT Annual Meeting Abstracts

Find out more

Charting the Course: Trends and Challenges in Early-Stage Cytokine-Based Drug Development Commercialization

Find out more

The 2023 Checkpoint Landscape Review

Find out more

Webinars

Breaking Down AACR: A Comprehensive Review of DDR-Related Abstracts

Find out more

Navigating the Liquid Biopsy Landscape and the Role of ctDNA in Lung Cancer Research

Find out more

Decoding the Bivalent Degrader Landscape – Novel PROTACs, Developer Trends, and Future Innovations

Find out more

ADC

Exploring the Synergy of ADCs in Combination with Checkpoints – A Comprehensive Review

Find out more

The 2023 ADC Landscape Review

Find out more

The Rise of ADCs and Novel Drug Conjugates in Asia

Find out more

Bispecific

The 2023 Bispecific Landscape Review

Find out more

Global Commercial Insights From the Bispecific and Multispecific Market

Find out more

The Rise of Bispecific Combination Trials Infographic

Find out more

Cancer Vaccine

2023 Cancer Vaccine Landscape Review

Find out more

Infographic 2023 Cancer Vaccine ESMO Abstracts Analysis

Find out more

SITC 2023 Cancer Vaccine Annual Meeting Abstracts

Find out more

Cell Therapy

2023 Cell Therapy Landscape Review

Find out more

Beacon Cell Therapy: ASH 2023 Conference Coverage

Find out more

SITC 2023 Cell Therapy Annual Meeting Abstracts

Find out more

Checkpoint

The 2023 Checkpoint Landscape Review

Find out more

Beacon Checkpoint: PD-L1: An Endless Classic or Passing Fancy?

Find out more

Checkpoint: ESMO Congress 2023 Abstracts

Find out more

Cytokine

Charting the Course: Trends and Challenges in Early-Stage Cytokine-Based Drug Development Commercialization

Find out more

The 2023 Cytokine Landscape Review

Find out more

Cytokine: ESMO Congress 2023 Abstracts

Find out more

DDR

Beacon DDR: AACR Post-Conference Report 2024

Find out more

Breaking Down AACR: A Comprehensive Review of DDR-Related Abstracts

Find out more

Beacon DDR: AACR Pre-Conference Planner 2024

Find out more

Gene Therapy

Beacon Gene Therapy: 2024 ASGCT Annual Meeting Abstracts

Find out more

2023 Gene Therapy Landscape Review

Find out more

Beacon Gene Therapy: 2023 ASH Annual Meeting Abstracts

Find out more

Immune Tolerance

2023 Immune Tolerance Landscape Review

Find out more

Monoclonal Antibodies (mAbs) Unveiled: A Comprehensive Review of the Landscape in Immune-Mediated Diseases Report 2023

Find out more

Allergies Report 2023

Find out more

Microbiome

Microbiome: Drug Development in Asia Infographic

Find out more

The 2023 Microbiome Landscape Review

Find out more

Unlocking the Value of Microbiome-Targeting Therapeutics in Combating Infectious Diseases

Find out more

Oncolytic Viruses

2023 Oncolytic Viruses Landscape Review

Find out more

Infographic 2023 Oncolytic Viruses ESMO Abstracts Analysis

Find out more

SITC 2023 Oncolytic Viruses Annual Meeting Abstracts

Find out more

RNA

Beacon RNA: AACR Post-Conference Report 2024

Find out more

The 2023 RNA Landscape Review

Find out more

RNA SITC Post-Conference Report 2023

Find out more

TPD

TPD: AACR Post-Conference Report 2024

Find out more

Decoding the Bivalent Degrader Landscape – Novel PROTACs, Developer Trends, and Future Innovations

Find out more

The 2023 TPD Landscape Review

Find out more

About Beacon

See how our clinical trials and drug database solutions in action

Request a demo

We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.

logo